EVUMED LIMITED

Evumed Limited is a forward‑thinking generic and biopharmaceutical company founded in 2025 and based in Cork, Ireland. Leveraging a fully integrated model that spans discovery, research and development, manufacturing and commercialisation, Evumed brings both generic and branded medicines, as well as biologic therapies, to market. By partnering with healthcare systems and a network of European stakeholders, the company works to improve patient outcomes and ensure a reliable, continuous supply of high‑quality, affordable medicines.

The firm’s core specialisation lies in maximising treatment accessibility. Its robust manufacturing capabilities enable rapid scale‑up and consistent delivery of products across the continent, while its dedicated R&D team drives innovation in generic, branded and biologic drug development. Evumed’s collaborative approach means it can respond swiftly to evolving healthcare needs, supporting patients, clinicians and payers alike.

Committed to advancing healthcare throughout Europe, Evumed invites partners and healthcare providers to explore its portfolio of medicines and joint‑venture opportunities, with a view to creating sustainable progress for the communities it serves.